In breast cancer, for instance, MT-CO1 and MT-CO3, associated with promoting cancer phenotype31,32, and RPL19, linked to poor patient survival33, were predominantly expressed in clones 2, 6, and 7. Here, RPL19 is linked to breast carcinoma.